Scope Biosciences B.V. has secured a follow-on investment from SHIFT Invest and Oost NL. The additional funding follows on the company's progression and first significant commercial traction. Including this new capital, together with a previously awarded €2.5 million EIC Transition Grant and earlier…Original Article